您的位置: 首页 > 农业专利 > 详情页

適用於預測對醋酸格拉替雷的臨床反應的單核苷酸多態性
专利权人:
TEVA PHARMACEUTICAL INDUSTRIES LTD.
发明人:
AMIR TCHELET,FABIO MACCIARDI,JOSEPH LEVY
申请号:
HK15100236.7
公开号:
HK1200274A
申请日:
2015.01.09
申请国别(地区):
HK
年份:
2015
代理人:
摘要:
This invention provides a method for treating a human subject afflicted with multiple sclerosis or a single clinical attack consistent with multiple sclerosis with a pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier, comprising the steps of 1) identifying whether the human subject is a predicted responder to glatiramer acetate by determining the genotype of the subject at one or more single nucleotide polymorphisms (SNPs) selected from the group consisting of the SNPs in Group 1; and 2) administering the pharmaceutical composition comprising glatiramer acetate and a pharmaceutically acceptable carrier to the subject only if the subject is identified as a predicted responder to glatiramer acetate.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充